Pets at Home focuses on UK pet retail, shares in FTSE sector comparison
Published on 06/26/2026 at 12:05 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSBy Julia Schmitt, Sector & Peer Group desk. Reviewed prior to publication on 2026-06-26, 12:04.
Pets at Home (GB00B29H4253) is a leading UK-listed pet care retailer with a broad footprint in specialty stores and veterinary services across Britain. The stock trades on the London Stock Exchange, where it is often compared with US peers such as Petco Health and Wellness and online players like Chewy in sector analyses.
UK pet retail positioning
Pets at Home operates more than 450 retail locations in the UK, combining pet supplies, grooming and in-store veterinary services under the Vets4Pets brand, according to its investor information. The group targets a mix of discretionary and recurring spending on pet food, healthcare and accessories, a set-up designed to balance consumer cycles.
Sector commentators frequently benchmark Pets at Home’s retail model against US chains such as Petco Health and Wellness, which focuses on pet products and veterinary clinics, and online competitors like Chewy, which emphasize subscription-based food and supplies deliveries. This cross-market comparison helps investors assess how traditional multi-channel retail can compete with pure e-commerce offerings.
Friday sector and peer view
On recent data, US-listed Petco Health and Wellness carries a consensus rating between Hold and moderate Buy, with an average price target around $4.06 and Jefferies as one of the more optimistic houses at $5.00. This level of analyst scrutiny on a sector peer highlights how pet retail remains closely watched despite margin pressures and consumer-spending headwinds.
PetMed Express, another US pet-health peer, reported a fourth-quarter 2026 earnings per share of -$0.19, missing the consensus estimate of -$0.18 by $0.01. That miss underscores the uneven profitability across parts of the pet-care value chain, particularly in online pharmacy and prescription segments where competition and cost pressures are intense.
All news and data on the Pets at Home shares
Further updates, price data and background on Pets at Home are available in the dedicated topic section and via the company’s investor-relations page.
The business behind the stock
Pets at Home generates revenue primarily from pet food, accessories, grooming services and veterinary care bundled through its British store network and partner clinics. The integration of retail and medical services aims to keep customers within the ecosystem for both everyday purchases and essential pet healthcare.
Where the stock trades today
The Pets at Home shares (GB00B29H4253) trade on the London Stock Exchange; a recent market-capitalization snapshot and price quote can be obtained directly from the exchange and major financial-data providers. The latest verified price data, including intraday moves and currency, should be checked at the time of any investment decision.
Pets at Home at a glance
- Company: Pets at Home Group plc
- ISIN: GB00B29H4253
- WKN: B29H42
- Ticker: PETS
- Trading venue: London Stock Exchange
- Price (as of latest available data): [check current quote] GBP
- Market cap: [check current figure] GBP (as of latest available data)
- Sector / industry: Consumer Discretionary, Specialty Retail, Pet Care
- Index membership: FTSE index family, including mid-cap and sector indices where applicable
- Next earnings date: not officially scheduled
Disclaimer: This text is for informational purposes only and does not constitute investment advice, a recommendation or a solicitation to buy or sell securities. Data points and peer comparisons are based on sources believed to be reliable at the time of writing but may change without notice.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
